The Lancet Neurology
Fecha de publicación: 8 April 2019
DOI: https://doi.org/10.1016/S1474-4422(19)30044-4
Autores: Anat Mirelman, PhD., Paolo Bonato, PhD., Richard Camicioli, MDCM., Terry D Ellis, PhD., Prof Nir Giladi, MD., Jamie L Hamilton, PhD
et al.
Background: Gait impairments are among the most common and disabling symptoms of Parkinson’s disease. Nonetheless, gait is not routinely assessed quantitatively but is described in general terms that are not sensitive to changes ensuing with disease progression.
